1-1 of 1
Lisa Harton
Close
Sort by
Journal Articles

EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT

Akil A. Merchant, Aparna Jorapur, Amy McManus, Ren Liu, Valery Krasnoperov, Parvesh Chaudhry, Mohan Singh, Lisa Harton, Mary Agajanian, Miriam Kim, Timothy J. Triche, Jr, Brian J. Druker, Jeffrey W. Tyner, Parkash S. Gill
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1635–1644.
https://doi.org/10.1182/bloodadvances.2017005694
Published: 2017
Includes: Supplemental data